世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

細胞培養液市場：タイプ別（無血清（CHO、BHK、Vero Cell）、幹細胞、化学修飾、クラシック、特殊）、用途別（バイオ医薬品（mAbs、ワクチン）、診断薬、組織工学）、エンドユーザー（医薬品、バイオテクノロジー）-2026年までの世界市場予測


Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) - Global Forecast to 2026

細胞培養液の世界市場は、2021年の49億米ドルから2026年には103億米ドルに達すると予測されており、2021年から2026年の間に16.0%のCAGRで成長しています。この市場の成長は、細胞ベースのワクチンの利点に関する... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2022年3月3日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		291 355 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

細胞培養液の世界市場は、2021年の49億米ドルから2026年には103億米ドルに達すると予測されており、2021年から2026年の間に16.0%のCAGRで成長しています。この市場の成長は、細胞ベースのワクチンの利点に関する意識の高まり、モノクローナル抗体（mAb）の需要の増加、細胞ベースの研究への資金提供、幹細胞研究の成長、市場プレイヤーによる新しい細胞培養液の投入、個別医療への注目度が高まることが主な要因になっています。一方、細胞生物学研究にかかるコストの高さが、この市場の成長を抑制しています。

「予測期間中の細胞培養液市場のタイプ別成長率は、無血清培地が最も高かった。
2020年では、無血清培地セグメントが最大のシェアを占めています。これは、無血清培地が他の種類の培地と比較して、安定した性能、成長・生産性の向上、生理学的反応性のより良い制御、細胞培養における血清由来不定物による汚染リスクの低減などの利点があることに起因していると考えられる。
サーモフィッシャーサイエンティフィック社（Thermo Fisher Scientific, Inc.(米国）、Merck KGaA（ドイツ）、Danaher Corporation（米国）、Sartorius AG（ドイツ）、Corning Incorporated（米国）、富士フイルムアーバインサイエンティフィック株式会社（米国）、Thermo Fisher Scientific, Inc.(米国)、Merck KGaA（ドイツ）、FUJIFILM Irvine Scientific, Inc.(日本）、Lonza Group AG（スイス）、Becton, Dickinson and Company（米国）、MiltenyBiotec（ドイツ）、HiMedia Laboratories Pvt.Ltd. (米国)、FUJIFILM Irvine Scientific Inc.(インド)、STEMCELL Technologies Inc.(カナダ)、Biologos LLC (米国)、Cell Applications, Inc.(米国）などが挙げられます。

"アジア太平洋地域細胞培養液市場で最も成長率の高い地域" とあります。
細胞培養液市場は、北米、欧州、アジア太平洋地域、中南米（LATAM）、中東・アフリカ（MEA）に区分されます。アジア太平洋地域は、予測期間中に17.5%という最も高いCAGRを記録すると予想されます。老年人口の増加、有利な規制ガイドライン、細胞培養ベースのワクチン生産に対する政府の支援、低い製造コスト、アジアの新興経済国に対する世界の市場プレイヤーの注目度の高まりなどが、アジア太平洋地域の細胞培養液市場の成長に寄与する主な要因です。

本レポートのために実施した一次インタビューは、以下のように分類されます。

- 回答者別供給側80％、需要側20
- 職位別Cレベル：45％、Dレベル：30％、その他：25
- 地域別北米20％、欧州10％、アジア太平洋55％、中南米10％、中近東・アフリカ5
報告書に掲載された企業一覧
- サーモフィッシャーサイエンティフィック（Thermo Fisher Scientific Inc.(米国)
- メルクKGaA（ドイツ）
- ダナハーコーポレーション（米国）
- コーニング・インコーポレイテッド（米国）
- サルトリウスAG（ドイツ）
- 富士フイルムアーバインサイエンティフィック株式会社(日本)
- ロンザグループAG（スイス）
- ベクトン・ディッキンソン アンド カンパニー（米国）
- ミルテニー・バイオテック（ドイツ）
- ハイメディアラボラトリーズPVT LTD.(インド)
- STEMCELL Technologies Inc.(カナダ)
- バイオロゴス・エルエルシー（米国）
- セルアプリケーション社(米国)
- ケーソン・ラボラトリーズ・インク(米国)
- プロモセルGmbH（ドイツ）
- セルバイオロジクス社(米国)
- インビボジェン社（フランス）
- PAN-Biotech GmbH（ドイツ）
- ペプロテック社（PeproTech, Inc.(米国)
- セルラーテクノロジーLLC（米国）
- ゼンバイオ社(米国)
- アテナ環境科学株式会社(米国)
- サイゲン バイオサイエンシズ (米国)
- ビオウェストSAS（フランス）
- アクロンバイオテック社（米国）
調査範囲
本レポートは、細胞培養基材市場の詳細なイメージを提供します。種類、用途、エンドユーザー、地域などの異なるセグメントにおける市場規模と将来の成長性を推定することを目的としています。また、彼らの会社概要、最近の動向や主要な市場戦略と一緒にofthe主要な市場プレーヤーの詳細な競合分析が含まれています。

レポート購入の主なメリット
本レポートは、細胞培養メディウム市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することにより、市場のリーダー/新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、より良いビジネスの位置付けと適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、ステークホルダーが市場の脈動を理解し、主要な市場ドライバー、阻害要因、課題、トレンド、機会に関する情報を提供することを可能にします。

　

ページTOPに戻る


　

Summary

The global cell culture media market is projected to USD USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026.The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market.

“The serum-free media segmentaccounted for the highest growth rate in the cell culturemedia market, bytype, during the forecast period”
In 2020, the serum-free media segment accounted for the largest share of the market. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth & productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture.
Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), MiltenyiBiotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US)are some of the major players operating in the cell culturemedia market.

“Asia Pacific: The fastest-growing regionin thecell culturemedia market”
Thecell culturemedia market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific market is expected to register the highest CAGR of 17.5% during the forecast period. The growing geriatric population, favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian economies are the major factors contributing to the growth of the cell culture media market in the Asia Pacific.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level - 45%, D-level - 30%, and Others - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Corning Incorporated (US)
• Sartorius AG (Germany)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Becton, Dickinson and Company (US)
• MiltenyiBiotec (Germany)
• HiMedia Laboratories Pvt. Ltd. (India)
• STEMCELL Technologies Inc. (Canada)
• Biologos LLC (US)
• Cell Applications, Inc. (US)
• Caisson Laboratories Inc. (US)
• PromoCell GmbH (Germany)
• Cell Biologics, Inc. (US)
• InvivoGen (France)
• PAN-Biotech GmbH (Germany)
• PeproTech, Inc. (US)
• Cellular Technology Limited, LLC (US)
• ZenBio, Inc. (US)
• Athena Environmental Sciences, Inc. (US)
• Cyagen Biosciences (US)
• Biowest SAS (France)
• Akron Biotech (US)
Research Coverage:
This report provides a detailed picture of thecell culturemedia market. It aims at estimating the size and future growth potential of the market across different segments such as thetype, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture mediamarketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 39
1.1 OBJECTIVES OF THE STUDY 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 39
1.3 MARKET SCOPE 40
1.3.1 MARKETS COVERED 40
1.3.2 YEARS CONSIDERED FOR THE STUDY 41
1.4 CURRENCY 41
1.5 LIMITATIONS 41
1.6 STAKEHOLDERS 42
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
FIGURE 1 RESEARCH DESIGN 43
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 45
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MEDIA MARKET 45
2.2 MARKET ESTIMATION METHODOLOGY 46
FIGURE 3 CELL CULTURE MEDIA MARKET SIZE ESTIMATION
 (SUPPLY-SIDE ANALYSIS), 2020 46
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020 47
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 48
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 48
2.3 MARKET GROWTH RATE PROJECTIONS 49
FIGURE 6 CELL CULTURE MEDIA MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 49
FIGURE 7 CELL CULTURE MEDIA MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 50
2.4 DATA TRIANGULATION 51
FIGURE 8 DATA TRIANGULATION METHODOLOGY 51
2.5 RESEARCH ASSUMPTIONS 52
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 52
2.6 RISK ANALYSIS 53
 
3 EXECUTIVE SUMMARY 54
FIGURE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 54
FIGURE 10 CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2021 VS. 2026 (USD MILLION) 55
FIGURE 11 CELL CULTURE MEDIA MARKET, BY END USER, 
2021 VS. 2026 (USD MILLION) 56
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MEDIA MARKET 57
4 PREMIUM INSIGHTS 58
4.1 CELL CULTURE MEDIA MARKET OVERVIEW 58
FIGURE 13 RISING R&D SPENDING IN PHARMA COMPANIES AND EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES WILL 
DRIVE MARKET GROWTH 58
4.2 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE AND COUNTRY (2020) 59
FIGURE 14 SERUM-FREE MEDIA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN CELL CULTURE MEDIA MARKET IN 2020 59
4.3 CELL CULTURE MEDIA MARKET SHARE, BY APPLICATION, 2021 VS. 2026 60
FIGURE 15 BIOPHARMACEUTICAL PRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026 60
4.4 CELL CULTURE MEDIA MARKET, BY END USER, 2020 (USD MILLION) 60
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED THE MARKET IN 2020 60
4.5 CELL CULTURE MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE CELL CULTURE MEDIA MARKET FROM 2021 TO 2026 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 18 CELL CULTURE MEDIA MARKET: DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES 62
TABLE 1 CELL CULTURE MEDIA MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Rising R&D spending in pharmaceutical companies 64
FIGURE 19 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 64
5.2.1.2 Emerging cell culture technologies for cell-based vaccines 64
TABLE 2 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA 65
5.2.1.3 Increasing demand for monoclonal antibodies 65
TABLE 3 APPROVED MONOCLONAL ANTIBODIES BY US FDA FOR THERAPEUTIC USE 66
5.2.1.4 Growth in stem cell research 67
5.2.1.5 Launch of new cell culture media products by market players 68
5.2.1.6 Growing focus on personalized medicine 68
TABLE 4 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES 69
FIGURE 20 GROWING NUMBER OF FDA APPROVALS FOR PERSONALIZED MEDICINES 69
5.2.2 RESTRAINTS 69
5.2.2.1 Expensive cell biology research products 69
5.2.2.2 Ethical concerns regarding cell biology research 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 Advancements in 3D cell culture 70
5.2.3.2 Increasing incidence of infectious diseases and outbreaks of pandemics 71
5.2.3.3 Emerging markets 71
5.2.4 CHALLENGES 72
5.2.4.1 Survival of small players and new entrants 72
5.3 RANGES/SCENARIOS 73
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE CELL CULTURE MEDIA MARKET 73
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
FIGURE 22 REVENUE SHIFT & NEW REVENUE POCKETS FOR 
CELL CULTURE MEDIA PROVIDERS 74
5.5 IMPACT OF THE COVID-19 OUTBREAK ON THE CELL CULTURE MEDIA MARKET 74
FIGURE 23 CELL CULTURE MEDIA MARKET SCENARIO WITH AND WITHOUT 
COVID-19 IMPACT, 2019–2021 75
5.6 PRICING ANALYSIS 77
TABLE 5 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020) 77
5.7 PATENT ANALYSIS 78
FIGURE 24 PATENT APPLICATIONS FOR THE CELL CULTURE MEDIA MARKET, 
JANUARY 2011–FEBRUARY 2022 78
TABLE 6 INDICATIVE LIST OF PATENTS IN THE CELL CULTURE MEDIA MARKET 78
5.8 VALUE CHAIN ANALYSIS 79
FIGURE 25 VALUE CHAIN ANALYSIS OF THE CELL CULTURE MEDIA MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 79
5.9 SUPPLY CHAIN ANALYSIS 80
FIGURE 26 CELL CULTURE MEDIA MARKET: SUPPLY CHAIN ANALYSIS 81
5.10 ECOSYSTEM ANALYSIS OF THE CELL CULTURE MEDIA MARKET 81
TABLE 7 SUPPLY CHAIN ECOSYSTEM 82
5.11 PORTER’S FIVE FORCES ANALYSIS 84
TABLE 8 CELL CULTURE MEDIA MARKET: PORTER’S FIVE FORCES ANALYSIS 84
5.11.1 THREAT OF NEW ENTRANTS 84
5.11.2 THREAT OF SUBSTITUTES 84
5.11.3 BARGAINING POWER OF SUPPLIERS 84
5.11.4 BARGAINING POWER OF BUYERS 84
5.12 REGULATORY ANALYSIS 85
5.12.1 US 85
5.12.2 EUROPE 85
 
6 CELL CULTURE MEDIA MARKET, BY TYPE 87
6.1 INTRODUCTION 88
TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 88
6.1.1 SERUM-FREE MEDIA 89
TABLE 10 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 89
TABLE 11 SERUM-FREE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 90
TABLE 12 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 90
TABLE 13 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 91
TABLE 14 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 91
TABLE 15 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 91
TABLE 16 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 92
6.1.1.1 CHO media 92
6.1.1.1.1 Growing adoption of CHO media in biopharmaceutical companies to drive the growth of this market segment 92
TABLE 17 CHO MEDIA OFFERED BY KEY MARKET PLAYERS 92
TABLE 18 CHO MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 93
TABLE 19 NORTH AMERICA: CHO MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 93
TABLE 20 EUROPE: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93
TABLE 21 ASIA PACIFIC: CHO MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 94
TABLE 22 LATIN AMERICA: CHO MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 94
6.1.1.2 HEK 293 media 94
6.1.1.2.1 Advantages of HEK 293 cell lines are expected to drive the growth of this market segment 94
TABLE 23 HEK 293 MEDIA OFFERED BY KEY MARKET PLAYERS 95
TABLE 24 HEK 293 MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 95
TABLE 25 NORTH AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 96
TABLE 26 EUROPE: HEK 293 MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 96
TABLE 27 ASIA PACIFIC: HEK 293 MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 96
TABLE 28 LATIN AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 97
6.1.1.3 BHK media 97
6.1.1.3.1 BHK media have wide applications in the production of recombinant proteins 97
TABLE 29 BHK MEDIA OFFERED BY KEY MARKET PLAYERS 97
TABLE 30 BHK MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 31 NORTH AMERICA: BHK MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 98
TABLE 32 EUROPE: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 33 ASIA PACIFIC: BHK MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 99
TABLE 34 LATIN AMERICA: BHK MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 99
6.1.1.4 Vero cell media 99
6.1.1.4.1 Increasing role of Vero cells in research pertaining to viral vaccines to drive the growth of this market segment 99
TABLE 35 VERO CELL MEDIA OFFERED BY KEY MARKET PLAYERS 100
TABLE 36 VERO CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 100
TABLE 37 NORTH AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 101
TABLE 38 EUROPE: VERO CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 101
TABLE 39 ASIA PACIFIC: VERO CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 101
TABLE 40 LATIN AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 102
6.1.1.5 Serum-free stem cell media 102
6.1.1.5.1 Availability of funding for stem cell research driving the growth of this market segment 102
TABLE 41 SERUM-FREE STEM CELL MEDIA OFFERED BY KEY MARKET PLAYERS 103
TABLE 42 SERUM-FREE STEM CELL MEDIA MARKET, BY REGION, 
2019–2026 (USD MILLION) 104
TABLE 43 NORTH AMERICA: SERUM-FREE STEM CELL MEDIA MARKET,
 BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 44 EUROPE: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 104
TABLE 45 ASIA PACIFIC: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 46 LATIN AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
6.1.1.6 Insect cell media 105
6.1.1.6.1 Growing adoption of insect cell media for heterologous protein expression driving the growth of this market segment 105
TABLE 47 INSECT CELL MEDIA OFFERED BY KEY MARKET PLAYERS 106
TABLE 48 INSECT CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 49 NORTH AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 107
TABLE 50 EUROPE: INSECT CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 107
TABLE 51 ASIA PACIFIC: INSECT CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 107
TABLE 52 LATIN AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 108
6.1.1.7 CAR T-cell media 108
6.1.1.7.1 Growing demand for adoptive T-cell therapy to drive the growth of this market segment 108
TABLE 53 CAR T-CELL MEDIA OFFERED BY KEY MARKET PLAYERS 108
TABLE 54 CAR T-CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 109
TABLE 55 NORTH AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 109
TABLE 56 EUROPE: CAR T-CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 109
TABLE 57 ASIA PACIFIC: CAR T-CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 110
TABLE 58 LATIN AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 110
6.1.1.8 Other serum-free media 110
TABLE 59 OTHER SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 111
TABLE 60 OTHER SERUM-FREE MEDIA MARKET, BY REGION, 
2019–2026 (USD MILLION) 111
TABLE 61 NORTH AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 111
TABLE 62 EUROPE: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 112
TABLE 63 ASIA PACIFIC: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 112
TABLE 64 LATIN AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 113
6.1.2 CLASSICAL MEDIA & SALTS 113
6.1.2.1 Wide use of classical media & salts across all types of cell culture applications to drive the growth of this market segment 113
TABLE 65 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS 113
TABLE 66 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 
2019–2026 (USD MILLION) 114
TABLE 67 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 
026 (USD MILLION) 115
TABLE 69 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 115
TABLE 70 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 115
6.1.3 STEM CELL CULTURE MEDIA 116
6.1.3.1 Increasing collaborations between universities and pharma-biotech companies for stem cell research to drive the growth of this market segment 116
TABLE 71 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 116
TABLE 72 STEM CELL CULTURE MEDIA MARKET, BY REGION, 
2019–2026 (USD MILLION) 117
TABLE 73 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
TABLE 74 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 118
TABLE 75 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 118
TABLE 76 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 118
6.1.4 CHEMICALLY DEFINED (CD) MEDIA 119
6.1.4.1 Ability of CD media to increase reproducibility to drive the growth of this market segment 119
TABLE 77 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS 119
TABLE 78 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 
2019–2026 (USD MILLION) 119
TABLE 79 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 120
TABLE 80 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 120
TABLE 81 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 120
TABLE 82 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
6.1.5 SPECIALTY MEDIA 121
6.1.5.1 Ability of primary cells to proliferate in specialty media is expected to fuel the growth of this market segment 121
TABLE 83 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS 121
TABLE 84 SPECIALTY MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 122
TABLE 85 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 122
TABLE 86 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 123
TABLE 87 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 123
TABLE 88 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 123
6.1.6 OTHER CELL CULTURE MEDIA 124
TABLE 89 OTHER CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 124
TABLE 90 OTHER CELL CULTURE MEDIA MARKET, BY REGION, 
2019–2026 (USD MILLION) 125
TABLE 91 NORTH AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 125
TABLE 92 EUROPE: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 125
TABLE 93 ASIA PACIFIC: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 126
TABLE 94 LATIN AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 126
 
7 CELL CULTURE MEDIA MARKET, BY APPLICATION 127
7.1 INTRODUCTION 128
TABLE 95 CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 128
7.2 BIOPHARMACEUTICAL PRODUCTION 128
TABLE 96 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, 
BY REGION, 2019–2026 (USD MILLION) 129
TABLE 97 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 129
TABLE 98 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 99 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 100 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 101 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION,
 BY TYPE, 2019–2026 (USD MILLION) 131
7.2.1 MONOCLONAL ANTIBODY PRODUCTION 131
7.2.1.1 Growing demand for monoclonal antibody production is fueling the growth of this market segment 131
TABLE 102 INDICATIVE LIST OF APPROVED ANTIBODY PRODUCTS PRODUCED
 IN CHO CELLS 132
TABLE 103 INDICATIVE LIST OF MONOCLONAL ANTIBODIES WITH FDA AUTHORIZATION 132
TABLE 104 CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2019–2026 (USD MILLION) 133
TABLE 105 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 106 EUROPE: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 134
TABLE 107 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 134
TABLE 108 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 135
7.2.2 VACCINE PRODUCTION 135
7.2.2.1 Growing government support for vaccine production to drive the growth of this market segment 135
TABLE 109 NIH FUNDING FOR VACCINE RESEARCH, 2018–2022 (USD MILLION) 136
TABLE 110 CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY REGION, 2019–2026 (USD MILLION) 136
TABLE 111 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 112 EUROPE: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, 
BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 113 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 114 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 138
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION 138
TABLE 115 CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 116 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 139
TABLE 117 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 118 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 119 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 141
7.3 DIAGNOSTICS 141
7.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 141
TABLE 120 CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY REGION, 
2019–2026 (USD MILLION) 142
TABLE 121 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, 
BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 122 EUROPE: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 143
TABLE 123 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, 
BY COUNTRY, 2019–2026 (USD MILLION) 143
TABLE 124 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, 
BY COUNTRY, 2019–2026 (USD MILLION) 144
7.4 DRUG SCREENING & DEVELOPMENT 144
7.4.1 ADOPTION OF CELL-BASED ASSAYS IN DRUG DISCOVERY WILL DRIVE THE GROWTH OF THIS MARKET SEGMENT 144
TABLE 125 CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, 
BY REGION, 2019–2026 (USD MILLION) 145
TABLE 126 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 145
TABLE 127 EUROPE: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 145
TABLE 128 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 146
TABLE 129 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION) 146
7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE 146
TABLE 130 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 131 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION) 147
TABLE 132 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 133 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 134 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 135 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 149
7.5.1 CELL & GENE THERAPY 149
7.5.1.1 Increasing adoption of cell and gene therapies for treating patients to fuel the growth of this market 149
TABLE 136 CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY REGION, 2019–2026 (USD MILLION) 150
TABLE 137 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 150
TABLE 138 EUROPE: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, 
BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 139 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, 
BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 140 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 152
7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 152
TABLE 141 CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 
2019–2026 (USD MILLION) 152
TABLE 142 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 143 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 144 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 145 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 154
7.6 OTHER APPLICATIONS 154
TABLE 146 CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 154
TABLE 147 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 148 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, 
BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 149 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, 
BY COUNTRY, 2019–2026 (USD MILLION) 155
TABLE 150 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 156
8 CELL CULTURE MEDIA MARKET, BY END USER 157
8.1 INTRODUCTION 158
TABLE 151 CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION) 158
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 158
8.2.1 INCREASING RESEARCH EXPENDITURE BY PHARMA AND BIOTECH COMPANIES WILL DRIVE THE GROWTH OF THIS SEGMENT 158
TABLE 152 CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 159
TABLE 153 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 159
TABLE 154 EUROPE: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 160
TABLE 155 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 160
TABLE 156 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 161
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 161
8.3.1 INCREASING APPLICATIONS OF CELL CULTURE MEDIA IN DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS SEGMENT 161
TABLE 157 CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 162
TABLE 158 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 162
TABLE 159 EUROPE: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 163
TABLE 160 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 163
TABLE 161 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 164
8.4 RESEARCH & ACADEMIC INSTITUTES 164
8.4.1 GROWING PREVALENCE OF CANCER AND INCREASING RESEARCH FUNDING TO DRIVE THE GROWTH OF THIS SEGMENT 164
TABLE 162 CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, 
BY REGION, 2019–2026 (USD MILLION) 165
TABLE 163 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 165
TABLE 164 EUROPE: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 166
TABLE 165 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 166
TABLE 166 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 167
8.5 OTHER END USERS 167
TABLE 167 CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY REGION, 
2019–2026 (USD MILLION) 168
TABLE 168 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, 
BY COUNTRY, 2019–2026 (USD MILLION) 168
TABLE 169 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER END USERS,
 BY COUNTRY, 2019–2026 (USD MILLION) 169
TABLE 170 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, 
BY COUNTRY, 2019–2026 (USD MILLION) 169
TABLE 171 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, 
BY COUNTRY, 2019–2026 (USD MILLION) 169
 
9 CELL CULTURE MEDIA MARKET, BY REGION 170
9.1 INTRODUCTION 171
TABLE 172 CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 171
9.2 NORTH AMERICA 171
FIGURE 27 NORTH AMERICA: CELL CULTURE MEDIA MARKET SNAPSHOT 172
TABLE 173 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 172
TABLE 174 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 173
TABLE 175 NORTH AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 176 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 174
TABLE 177 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 178 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 179 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 175
9.2.1 US 175
9.2.1.1 Growing pharmaceutical and biotechnology sector in the US to drive market growth 175
TABLE 180 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 181 US: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 176
TABLE 182 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 177
TABLE 183 US: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 184 US: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 185 US: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 178
9.2.2 CANADA 178
9.2.2.1 Increase in stem cell research funding in Canada to fuel market growth 178
TABLE 186 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 179
TABLE 187 CANADA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 179
TABLE 188 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 180
TABLE 189 CANADA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 190 CANADA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 191 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 181
9.3 EUROPE 181
TABLE 192 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY,
 2019–2026 (USD MILLION) 182
TABLE 193 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 182
TABLE 194 EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,
 2019–2026 (USD MILLION) 183
TABLE 195 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION,
 2019–2026 (USD MILLION) 183
TABLE 196 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 197 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 198 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 184
9.3.1 GERMANY 185
9.3.1.1 Strong growth in the biotechnology industry in Germany to drive market growth 185
TABLE 199 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 185
TABLE 200 GERMANY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 186
TABLE 201 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION,
 2019–2026 (USD MILLION) 186
TABLE 202 GERMANY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 203 GERMANY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 204 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 187
9.3.2 UK 188
9.3.2.1 Advancements in the life sciences sector to boost market 
growth in the UK 188
TABLE 205 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 206 UK: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,
 2019–2026 (USD MILLION) 189
TABLE 207 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 189
TABLE 208 UK: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 209 UK: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 210 UK: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 190
9.3.3 FRANCE 191
9.3.3.1 Increase in government funding for life science research to drive market growth in France 191
TABLE 211 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 191
TABLE 212 FRANCE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 192
TABLE 213 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 192
TABLE 214 FRANCE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 215 FRANCE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 216 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 193
9.3.4 ITALY 194
9.3.4.1 Growing support for life science research in Italy to 
fuel market growth 194
TABLE 217 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 218 ITALY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 195
TABLE 219 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 196
TABLE 220 ITALY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 221 ITALY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 222 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 197
9.3.5 SPAIN 197
9.3.5.1 Advancement of translational personalized medicine to aid market growth in Spain 197
TABLE 223 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 224 SPAIN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 198
TABLE 225 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 199
TABLE 226 SPAIN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 227 SPAIN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 228 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 200
9.3.6 REST OF EUROPE 200
TABLE 229 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 230 ROE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 201
TABLE 231 ROE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 201
TABLE 232 ROE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 233 ROE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 234 ROE: CELL CULTURE MEDIA MARKET, BY END USER
2019–2026 (USD MILLION) 202
9.4 ASIA PACIFIC 203
FIGURE 28 ASIA PACIFIC: CELL CULTURE MEDIA MARKET SNAPSHOT 204
TABLE 235 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 204
TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 205
TABLE 237 ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 205
TABLE 238 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 206
TABLE 239 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 240 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 241 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 207
9.4.1 CHINA 207
9.4.1.1 China to register the highest growth rate in the Asia Pacific cell culture media market during the forecast period 207
TABLE 242 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 243 CHINA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 208
TABLE 244 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 209
TABLE 245 CHINA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 246 CHINA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 247 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 210
9.4.2 JAPAN 210
9.4.2.1 Increasing geriatric population along with rising cancer cases to drive market growth in Japan 210
TABLE 248 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 249 JAPAN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 211
TABLE 250 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 212
TABLE 251 JAPAN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 252 JAPAN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 253 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER,
 2019–2026 (USD MILLION) 213
9.4.3 INDIA 213
9.4.3.1 Government support for scientific research and expansion of the pharma-biotech sector to drive market growth in India 213
TABLE 254 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 255 INDIA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 214
TABLE 256 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 215
TABLE 257 INDIA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 258 INDIA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 259 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 216
9.4.4 REST OF ASIA PACIFIC 216
TABLE 260 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 216
TABLE 261 ROAPAC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 217
TABLE 262 ROAPAC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 217
TABLE 263 ROAPAC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 264 ROAPAC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 265 ROAPAC: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 218
9.5 LATIN AMERICA 219
TABLE 266 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 219
TABLE 267 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 219
TABLE 268 LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 269 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 220
TABLE 270 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 271 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 272 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 221
9.5.1 BRAZIL 222
9.5.1.1 Expanding pharmaceutical market in Brazil to fuel market growth 222
TABLE 273 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE,
 2019–2026 (USD MILLION) 222
TABLE 274 BRAZIL: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,
 2019–2026 (USD MILLION) 223
TABLE 275 BRAZIL: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 223
TABLE 276 BRAZIL: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 277 BRAZIL: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 278 BRAZIL: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 224
9.5.2 MEXICO 225
9.5.2.1 Growth in pharmaceutical R&D and manufacturing to drive the demand for cell culture media in Mexico 225
TABLE 279 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 225
TABLE 280 MEXICO: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 226
TABLE 281 MEXICO: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 226
TABLE 282 MEXICO: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 283 MEXICO: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 284 MEXICO: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 227
9.5.3 REST OF LATIN AMERICA 228
TABLE 285 ROLATAM: CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 228
TABLE 286 ROLATAM: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 
2019–2026 (USD MILLION) 228
TABLE 287 ROLATAM: CELL CULTURE MEDIA MARKET, BY APPLICATION, 
2019–2026 (USD MILLION) 229
TABLE 288 ROLATAM: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 289 ROLATAM: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 290 ROLATAM: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 230
9.6 MIDDLE EAST AND AFRICA 230
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS DRIVING MARKET GROWTH IN MEA 230
TABLE 291 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 292 MEA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,
 2019–2026 (USD MILLION) 231
TABLE 293 MEA: CELL CULTURE MEDIA MARKET, BY APPLICATION,
 2019–2026 (USD MILLION) 232
TABLE 294 MEA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 232
TABLE 295 MEA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION) 232
TABLE 296 MEA: CELL CULTURE MEDIA MARKET, BY END USER, 
2019–2026 (USD MILLION) 233
10 COMPETITIVE LANDSCAPE 234
10.1 OVERVIEW 234
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 234
FIGURE 29 KEY DEVELOPMENTS IN THE CELL CULTURE MEDIA MARKET, 2019–2022 235
10.3 MARKET SHARE ANALYSIS 236
FIGURE 30 CELL CULTURE MEDIA MARKET: MARKET SHARE ANALYSIS, 
BY KEY PLAYER, 2020 236
TABLE 297 CELL CULTURE MEDIA MARKET: DEGREE OF COMPETITION 236
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 238
FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE CELL CULTURE MEDIA MARKET, 2018–2020 238
10.5 COMPANY EVALUATION QUADRANT 238
10.5.1 STARS 239
10.5.2 EMERGING LEADERS 239
10.5.3 PERVASIVE PLAYERS 239
10.5.4 PARTICIPANTS 239
FIGURE 32 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT, 2020 240
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 241
10.6.1 PROGRESSIVE COMPANIES 241
10.6.2 STARTING BLOCKS 241
10.6.3 RESPONSIVE COMPANIES 241
10.6.4 DYNAMIC COMPANIES 241
FIGURE 33 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 242
10.7 PRODUCT FOOTPRINT OF COMPANIES 243
TABLE 298 PRODUCT PORTFOLIO ANALYSIS: CELL CULTURE MEDIA MARKET (2020) 243
10.8 REGIONAL FOOTPRINT OF COMPANIES 244
TABLE 299 REGIONAL FOOTPRINT OF COMPANIES: 
CELL CULTURE MEDIA MARKET (2020) 244
10.9 COMPETITIVE SCENARIO 245
TABLE 300 PRODUCT LAUNCHES 245
TABLE 301 DEALS 246
TABLE 302 EXPANSIONS 246
11 COMPANY PROFILES 247
11.1 KEY PLAYERS 247
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 247
TABLE 303 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 247
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020) 248
11.1.2 MERCK KGAA 253
TABLE 304 MERCK KGAA: BUSINESS OVERVIEW 253
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020) 254
11.1.3 DANAHER CORPORATION 257
TABLE 305 DANAHER CORPORATION: BUSINESS OVERVIEW 257
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 258
11.1.4 SARTORIUS AG 262
TABLE 306 SARTORIUS AG: BUSINESS OVERVIEW 262
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020) 263
11.1.5 CORNING INCORPORATED 266
TABLE 307 CORNING INCORPORATED: BUSINESS OVERVIEW 266
FIGURE 38 CORNING INCORPORATED: COMPANY SNAPSHOT (2020) 267
11.1.6 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION) 269
TABLE 308 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 269
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 270
11.1.7 LONZA GROUP AG 272
TABLE 309 LONZA GROUP AG: BUSINESS OVERVIEW 272
FIGURE 40 LONZA GROUP AG: COMPANY SNAPSHOT (2020) 273
11.1.8 BECTON, DICKINSON AND COMPANY (BD) 275
TABLE 310 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 275
FIGURE 41 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 276
11.1.9 MILTENYI BIOTEC 278
TABLE 311 MILTENYI BIOTEC: BUSINESS OVERVIEW 278
11.1.10 HIMEDIA LABORATORIES PVT. LTD. 279
TABLE 312 HIMEDIA LABORATORIES PVT. LTD.: BUSINESS OVERVIEW 279
11.1.11 STEMCELL TECHNOLOGIES INC. 283
TABLE 313 STEMCELL TECHNOLOGIES INC.: BUSINESS OVERVIEW 283
11.1.12 BIOLOGOS LLC. 285
TABLE 314 BIOLOGOS LLC.: BUSINESS OVERVIEW 285
11.2 OTHER PLAYERS 286
11.2.1 CELL APPLICATIONS, INC. 286
11.2.2 CAISSON LABORATORIES INC. 287
11.2.3 PROMOCELL GMBH 288
11.2.4 CELL BIOLOGICS, INC. 288
11.2.5 INVIVOGEN 289
11.2.6 PAN-BIOTECH GMBH 290
11.2.7 PEPROTECH, INC. 291
11.2.8 CELLULAR TECHNOLOGY LIMITED LLC. 292
11.2.9 ZEN-BIO, INC. 293
11.2.10 ATHENA ENVIRONMENTAL SCIENCES, INC. 294
11.2.11 CYAGEN BIOSCIENCES 294
11.2.12 BIOWEST SAS 295
11.2.13 AKRON BIOTECH 296
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 297
12.1 DISCUSSION GUIDE 297
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 300
12.3 AVAILABLE CUSTOMIZATIONS 302
12.4 RELATED REPORTS 302
12.5 AUTHOR DETAILS 303

 

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

MarketsandMarkets社の診断薬分野での最新刊レポート

本レポートと同じKEY WORD（mabs vaccine）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21　10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.